No Structure Information
This entry has no structure information.
To add it, be sure the Wikipedia entry contains a valid CAS number in its "Chembox", "Chembox new", "Drugbox", or "Explosivebox" template.
Even with a valid CAS number, structural information may not appear because of limitations in Chempedia's database. Stay tuned for developments in this area.
Omalizumab (marketed under the name Xolair) is a monoclonal antibody made by Genentech / Novartis and used mainly in allergy-related asthma therapy, with the purpose of reducing allergic hypersensitivity. Xolair (Omalizumab) is a recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). IgE is commonly involved with allergies when present in high amounts in the body.
3 edits since May 19, 2008. Last edited Jul 27, 2008 by anonymous (1073).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Omalizumab. See this site's terms for details.